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Background: There are a number of complications that can occur if there is under-nutrition during pregnancy
followed by a period of rapid catch-up growth, including a higher chance of adult obesity, insulin resistance and
hypertriglyceridemia. The purposes of this study were to investigate the effects of fetal under-nutrition during late
pregnancy and lactation on blood pressure, visceral fat tissue, gene expressions and to evaluate changes after
amlodipine- losartan combination treatment.
Methods: The rats were divided into three groups: the control (C) group, the food restriction (FR: 50 % food
restricted diet) group, and the CX group, which was treated with Cozaar XQ (amlodipine- losartan combination drug)
in FR rats from postnatal 4 to 20 weeks. Masson’s trichrome staining was performed in the heart tissues. The amount
of abdominal visceral fat tissues was measured. Western blot analysis such as angiotensin converting enzyme (ACE),
angiotensin II receptor type IA (ATIA), troponin I (Tn I) and endothelial nitric oxide synthase (eNOS) were performed.
Results: Body weights were significantly higher in the FR group compared with the C group at weeks 8 and 20 and
lower in the CX group at week 20. Blood pressure was significantly higher in the FR group compared with the C group
at week 20 and lower in the CX group at weeks 12 and 20. The amount of abdominal visceral fat was significantly
higher in the FR group compared with the C group at weeks 8, 12 and 20 and significantly lower in the CX group at
weeks 16 and 20. Protein expression of ATIA and eNOS were significantly reduced in the CX group at weeks 16 and 20.
ACE was significantly reduced in the CX group at week 20 and Tn I was significantly reduced in the CX group at
week 16.
Conclusions: When there is fetal under-nutrition during pregnancy, it leads to obesity, high blood pressure,
hypertriglyceridemia and several gene changes in offspring. Amlodipine-losartan combination treatment was
able to lower obesity, hypertension, hypertriglyceridemia and several gene changes in rats suffering from fetal
under-nutrition during pregnancy.
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Fetal programming, due to maternal under-nutrition, is
a critical problem, especially in developing countries. It
can lead to the development of metabolic syndrome
(MS), hypertension, coronary heart disease and diabetes
in adulthood [1]. Early prenatal events in the fetus can
result in cardiovascular and metabolic pathologies in both
in humans and experimental models [2, 3]. Although we
know little about the precise mechanisms of fetal pro-
graming, some mechanisms have been more extensively
studied including glucocorticoid exposure, the role of the
kidneys and the renin angiotensin system (RAS) [4, 5].
Other pathophysiological pathways have been investi-
gated, such as the role of the brain and oxidative stress,
sympathetic nervous system, and epigenetic changes [4].
Numerous methods have been employed to induce
fetal under-nutrition in animal studies such as maternal
under-nutrition during pregnancy [6], placental insuffi-
ciency [7], or pharmacological manipulations [8].
A reading of the research done in this field mentions a
variety of results. We can find evidence in the literature
for a link between fetal under-nutrition and an increased
risk of MS [3], but other research mentions just compo-
nents of MS, including hypertension [9], impaired glucose
tolerance and insulin resistance [10], dyslipidemia [11, 12],
obesity [13] and coronary heart disease [14].
Intrauterine growth retardation may result in a decrease
in the expression of genes involved in nephrogenesis [15],
as well as a re-directing of nutrients from the kidney to
more essential organs such as the brain, heart and adrenal
glands in order to increase the survival of the fetus [16].
Sun, et al. reported that offspring exposed to altered
maternal nutrition in utero showed modulation of gene
expression in adult life associated with subsequent hyper-
tension and dyslipidemia [17].
Blockade of the RAS prevents or gets rid of hyperten-
sion in fetal programming animal models, so RAS is
most-likely very important in the etiology of prenatal
programmed hypertension [6, 18]. There have been con-
troversies about the effect of antihypertensive drugs such
as losartan and angiotensin converting enzyme (ACE)
inhibitors on fetal programming models [19]. There have
yet to be any reports on the effects of a fixed-dose com-
bination therapy of amlodipine and losartan (Cozaar XQ)
in a fetal programming model. Our paper is the first to
study about an effect of amlodipine- losartan combination
in a fetal programming model.
The purposes of this study were to investigate the effects
of fetal under-nutrition during pregnancy and lactation on
abdominal visceral fat, lipid profiles, blood pressure and
several genes such as ACE, angiotensin II receptor type IA
(ATIA), troponin I (Tn I) and endothelial nitric oxide syn-
thase (eNOS) and evaluate changes after amlodipine-
losartan combination treatment.Methods
Animals
Nine to twelve weeks old virgin female Wistar rats (Sankyo
Lab Service, Tokyo, Japan) were maintained at 12 h light/
12 h darkness cycles with free access to tap water and
standard rat chow (laboratory animal diet MF; Oriental
Yeast, Tokyo, Japan). Female rats were mated with male
Wistar rats and conception was confirmed by the observa-
tions of semen plugs on the floor of the mating cage.
Pregnant rats were studied from the 10th day to term
gestation and through lactation.
Control pregnant rats were fed ad libitum (AdLib) food,
whereas the study rats were 50 % food restricted (FR).
In this study, only the male offsprings were used. The
rats were divided into three groups: the control (C)
group (n = 20), the food restriction (FR: 50 % food re-
striction diet (n = 40)] group, CX group (n = 40), which
was treated with Cozaar XQ (amlodipine- losartan
combination drug orally) in the FR rats from postnatal
4 to 20 weeks.
Food intake and maternal weights were recorded daily
until birth. After birth, body weight was recorded daily.
The rats were sacrificed at weeks 4, 8, 12, 16 and 20. The
heart and kidney tissues were removed and immediately
frozen at −70 °C for protein and gene analysis, post-fixed
in 10 % formalin, and processed routinely for paraffin em-
bedding. All protocols were approved by the Institutional
Animal Care and Use Committees of the School of Medi-
cine of Ewha Womans University (approval No. 13-0244).
Organ weights
The rats were weighed and their general appearance was
observed daily during the study period. The hearts and
kidneys were rapidly removed. The wet weights of the
left ventricle (LV) and kidney were measured.
Estimation of abdominal visceral fat tissues
The amount of abdominal visceral fat (mesenteric, peri-
renal and pararenal abdominal fat tissues) was estimated
at weeks 4, 8, 12, 16 and 20.
Estimation of systemic blood pressure
The animals were placed in the supine position and instru-
mented with an arterial pressure line (Physiological Pres-
sure Transducer, MLT 1199; AD Instruments, Oxfordshire,
UK). Arterial pressures were estimated at external carotid
artery using the input from an ambient-pressure reference
(APR-1; Data Sciences) at weeks 4, 8, 12, 16 and 20.
Morphometric analysis of the heart tissues
The LV including the interventricular septum was
weighed after the right and left atria and the right ven-
tricular free wall were dissected. The LV heart tissue was
Table 1 Changes of body weight in fetal programming model
after amlodipine-losartan combination treatment
Week C (g) FR (g) CX (g)
4 90.75 ± 8.33 85.66 ± 6.79 97.67 ± 21.26
8 302.50 ± 16.83 369.25 ± 28.15* 333.13 ± 27.54
12 395.125 ± 26.575 408.67 ± 24.95 400.875 ± 11.89
16 512.38 ± 20.90 541.50 ± 35.64 507.50 ± 15.21
20 553.50 ± 13.52 582.10 ± 19.70* 552.30 ± 1.09†
C control, FR food restriction, CX amlodipine- losartan combination
*C group vs FR group, p < 0.05, † FR group vs CX group, p < 0.05
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tion in all three groups.
Masson’s trichrome staining was used in order to ob-
serve the degree of fibrosis in the heart tissues. The area
with the most and least degree of fibrosis within each
group was selected and photographed under 200 HPF
light microscopy. The photographs were processed
through an image analysis program (analySIS).
Serum lipid profile
Blood was drawn from all the rats. They fasted for 12 h
prior to their blood draw to determine blood levels of
the following parameters: blood glucose, total cholesterol
(TC), high density lipoprotein-cholesterol (HDL-C), low
density lipoprotein-cholesterol (LDL-C), triglyceride
(TG) at weeks 4, 8, 12, 16 and 20.
Westernblot analysis of heart tissues
Whole tissue extracts from rat heart were prepared by
homogenization in lysis buffer (Proprep, Intron, Seongnam,
Korea). Lysates were normalized and separated on 8–12 %
polyacrylamide gels and transferred to nitrocellulose blot-
ting membranes (GE Healthcare: formerly Amersham Bio-
science, Munich, Germany). After staining with Ponceau
red, membranes blocked with 5 % bovine serum albumin
an hour at room temperature followed by incubation with
primary antibodies including four genes: ACE, ATIA, Tn I,
and eNOS (Santacruz Biotechnology, Santa Cruz, CA,
USA) overnight.
Nitrocellulose membranes were then washed in t-TBS.
The membranes were incubated with horseradish con-
jugated secondary antibodies for one hour at room
temperature. The bound secondary antibody was detected
by ECL™ Western blotting detection reagents (GE Health-
care: formerly Amersham Bioscience, Buckinghamshire,
UK).
Statistical analysis
Results are expressed as the mean ± standard deviation.
Data were analyzed using SPSS (SPSS v22.0, Chicago, IL,
USA) for windows. The Mann-Whitney test was used to
test for significant differences between the C and FR
group. The Kruskal-Wallis test was used to test for sig-
nificant differences between FT group and CX group.
Results
Body weights
There was no significant change in body weight at week
4 among the groups.
Body weight was significantly increased at week 8 in the
FR group compared with the C group (C vs. FR; 302.50 ±
16.83 g vs. 369.25 ± 28.15 g, p < 0.05), and at week 20 (C vs.
FR; 553.50 ± 13.52 g vs. 582.10 ± 19.70 g, p <0.05). Body
weight was significantly decreased in the CX groupcompared with the FR group at week 20 (FR vs. CX;
582.10 ± 19.70 g vs. 552.30 ± 1.09 g, p <0.05) (Table 1).
Abdominal fat tissues
Abdominal fat tissues were significantly increased in the
FR group compared with the C group at week 8 (C vs.
FR; 5.26 ± 0.14 g vs. 8.38 ± 0.45 g, p < 0.05), 12 (C vs. FR;
9.54 ± 0.59 g vs. 12.96 ± 1.01 g, p < 0.05), and 20 (C vs.
FR; 17.77 ± 2.23 g vs. 34.83 ± 10.47 g, p < 0.05) (Fig. 1).
Abdominal fat tissues were significantly reduced in the
CX group compared with the FR group at weeks 16 (FR vs.
CX; 24.44 ± 0.93 g vs. 18.20 ± 1.55 g, p < 0.05) and 20 (FR
vs. CX; 34.83 ± 10.47 g vs.18.36 ± 3.79 g, p < 0.05), (Fig. 1).
Blood pressure
Blood pressure was significantly increased in the FR group
compared with the C group at week 20 (119.80 ±
26.22 mmHg vs. 141.75 ± 19.70 mmHg) (p < 0.05, Table 2).
Blood pressure was significantly decreased in the CX
group compared with the FR group at week 12 (FR vs.
CX; 122.00 ± 9.9 mmHg vs.97.00 ± 1.73 mmHg and 20
(FR vs. CX; 141.75 ± 19.70 mmHg vs. 121.00 mmHg), p
<0.05, Table 2).
LV + S/RV ratio
There was no significant difference among the groups.
Data was not shown.
Pathologic finding in heart tissues
Under light microscopy, collagen was observed to pene-
trate between the LV myocardiocytes, staining blue as
noted in Fig. 2. The degree of collagen was not signifi-
cantly different in each group.
Westernblot analysis
Protein expressions of ACE (Fig. 3), AT1A (Fig. 4) and
eNOS (Fig. 5) were significantly increased in the FR group
compared with the C group at weeks 16 and 20. Protein
expressions of Tn I was significantly increased in the FR
group compared with the C group at week 16 (Fig. 6).
Protein expressions of ACE were significantly decreased




























Fig. 1 Abdominal fat tissues in fetal programming model after amlodipine–losartan combination treatment. Abdominal fat tissues were significantly
reduced in the CX group compared with the FR group at weeks 16 and 20. C, control; FR, food restriction; CX, Cozaar XQ. *p <0.05 C group vs FR
group, † p <0.05 FR group vs CX group
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(Fig. 5) were significantly decreased in the CX group com-
pared with the FR group at weeks 16 and 20. Protein ex-
pressions of Tn I were significantly decreased in the CX
group compared with the FR group at week 16 (Fig. 6).
Serum lipid profile
TG was significantly higher at weeks 8, 12 and 20 in the
FR group compared with the C group and decreased in
the CX group compared with FR group at week 20
(76.80 ± 13.03 mg/dL vs. 42.75 ± 10.34 mg/dL, p < 0.05).
TC, HDL-C and LDL-C were not significantly different
between groups (Table 3).
Discussion
Our research confirmed that fetal under-nutrition dur-
ing pregnancy resulted in obesity, high blood pressure,
hypertriglyceridemia and several gene changes in the
offspring.
Body weight was significantly increased at weeks 8 and
20 in the FR group. BP was significantly increased in the FR
group at week 20. Abdominal visceral fat was significantlyTable 2 Changes of blood pressure in fetal programming model
after amlodipine-losartan combination treatment
Week C (mmHg) FR (mmHg) CX (mmHg)
4 86.00 ± 12.73 82.50 ± 10.61 84.25 ± 6.24
8 100.00 ± 16.57 113.25 ± 5.32 101.75 ± 11.76
12 103.25 ± 6.99 122.00 ± 9.9 97.00 ± 1.73†
16 109.50 ± 3.32 103.67 ± 13.58 110.25 ± 10.24
20 119.80 ± 26.22 141.75 ± 19.70* 121.00 ± 00.00†
C control, FR food restriction, CX amlodipine-losartan combination
*C group vs FR group, p <0.05, † FR group vs CX group, p <0.05larger at weeks 8, 12 and 20 in the FR group. Protein ex-
pressions of ACE, AT1A, eNOS and Tn I were significantly
increased in the FR group. TG was significantly higher in
the FR group at weeks 8, 12 and 20.
Effects of amlodipine-losartan combination on fetal
programming model were as follows.
Body weight was significantly reduced in the CX group
compared with the FR group at week 20. Abdominal fat
tissues were significantly reduced in the CX group at
weeks 8, 12, 16 and 20. BP was significantly decreased in
the CX group at weeks 12 and 20. Protein expressions of
ACE, AT1A, eNOS and Tn I were significantly de-
creased in the FR group. TG was significantly decreased
in the CX group at week 20.
In our research, amlodipine-losartan combination treat-
ment in fetal programming model reduced obesity, hyper-
tension, hypertriglyceridemia and gene changes.
There has been some controversy related to the results of
fetal programing depending on the investigator. We’ve
noticed differences in the literature for the timing of the ap-
pearance of elevated BP, as well as its persistence. Most of
the research notes elevated BP in animal models between 9
and 12 weeks of age using low protein diet (LPD), reduced
uterine perfusion [20] or globally restricted diet [21].
But, the occurrence of the increased BP was differ-
ent in some research. In the offspring of dams sub-
jected to a 50 % caloric reduction, BP is significantly
increased at 4 weeks of age [20]. Vehaskari, et al. re-
ported that after 12 weeks of age, BP either remained
unchanged or continued to elevate up to 10 months
of age [21]. In a Jansson study, BP appears to dimin-
ish as the subject gets older [22]. In our research, BP
was significantly increased in the FR group compared
with the C group at week 20.




Fig. 2 Pathologic finding in the heart tissues by Masson’s trichrome staining. There was not significantly different between groups. C, control; FR,
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Fig. 3 ACE protein in the heart tissues by westernblot analysis. Protein expressions of ACE were significantly decreased in the CX group compared
with the FR group at week 20. ACE, angiotensin converting enzyme; C, control; FR, food restriction; CX, Cozaar XQ. *p <0.05 C group vs
FR group, † p <0.05 FR group vs CX group
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Fig. 4 AT1A protein in the heart sissues by westernblot analysis. Protein expressions of AT1A were significantly decreased in the CX group compared
with the FR group at weeks 16 and 20. AT IA; angiotensin receptor type IA; C, control; FR, food restriction; CX, Cozaar XQ. *p <0.05 C group vs FR
group, † p <0.05 FR group vs CX group
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in fetal programming models, persisting in subjects for
up to 7 years of age [8].
The mechanisms of hypertension in fetal program-
ming models are multi-factorial and complex. They
include changes of the RAS [23]. Sahajpal, et al. have
reported that renal AT1 receptor expressions in-
creased by 24 % in offspring of LPD dams [24]. This
suggests that activation of the RAS is one of the most




















Fig. 5 eNOS protein in the heart tissues by westernblot analysis. Protein expr
with the FR group at weeks 16 and 20. eNOS, endothelial nitric oxide
group vs FR group, † p <0.05 FR group vs CX groupmaternal calorie restriction. This finding was similar
with our data.
Also, changes of lipid metabolism on fetal programming
are different in some investigations [12, 19]. Intrauterine
under-nutrition has been linked with an elevated risk of
dyslipidemia and insulin resistance, a decrease in insulin
content [12] and hyperglycemia in female offspring [25] .
Lucas, et al. noted that dams who were provided with
a LPD in both pregnancy and lactation had offspring



















essions of eNOS were significantly decreased in the CX group compared
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Fig. 6 Troponin I protein in the heart tissues by westernblot analysis. Protein expressions of Tn I were significantly decreased in the CX group
compared with the FR group at week 16. Tn; troponin; C, control; FR, food restriction; CX, Cozaar XQ. *p <0.05 C group vs FR group, † p <0.05 FR
group vs CX group
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pared with the control group [26]. However, Desai, et al.
showed that 6-month-old offspring given 50 % food re-
striction during pregnancy and the lactation period lead
to higher TG and normal TC concentrations than the
control group [27]. In our research, serum TG was sig-
nificantly increased in our fetal programming model at
weeks 8, 12 and 20.
Mechanism involved in fetal programming may de-
pend on the duration and timing of nutritional insultTable 3 Changes of serum lipid profile in fetal programming mode
Week Blood sugar (mg/dL) TG (mg/dL)
4 C 288.50 ± 142.13 107.50 ± 62.98
FR 237.00 ± 108.43 142.00 ± 47.76
CX 205.00 ± 0.00 83.00 ± 2.83
8 C 202.00 ± 14.72 45.75 ± 14.24
FR 207.50 ± 58.34 145.50 ± 26.80*
CX 263.00 ± 25.87 105.50 ± 28.63
12 C 127.75 ± 10.21 20.25 ± 10.31
FR 101.00 ± 18.17 38.25 ± 7.50*
CX 165.00 ± 94.69 30.00 ± 8.54
16 C 169.33 ± 3.33 62.50 ± 14.50
FR 189.50 ± 11.32 81.50 ± 0.32
CX 191.67 ± 39.14 86.25 ± 32.93
20 C 141.17 ± 36.99 33.20 ± 13.31
FR 195.00 ± 22.58 76.80 ± 13.03*
CX 181.00 ± 19.61 42.75 ± 10.34†
C control, FR food restriction, CX amlodipine losartan-combination, TG triglyceride,
density lipoprotein cholesterol
*C group vs FR group, p <0.05, † FR group vs CX group, p <0.05[3]. When maternal under-nutrition creates in utero
stress, the developing fetus may reprogram the genome
to overcome the new, more dangerous environment.
This may favor immediate survival but it generally re-
sults in a predisposition to metabolic disease in adult
life. The development of subsequent chronic disease in
adulthood may depend on the amount of difference
between pre and postnatal environment [28].
In another study, increased methylation of retinoid X
receptor and eNOS were linked to larger adiposity inl after amlodipine-losartan combination treatment
TC (mg/dL) HDL-C (mg/dL) LDL-C (mg/dL)
84.33 ± 3.06 65.33 ± 11.93 18.00 ± 6.08
82.67 ± 2.52 66.67 ± 0.87 16.00 ± 4.58
76.50 ± 2.12 65.50 ± 0.72 18.00 ± 0.00
43.00 ± 6.78 40.50 ± 6.24 4.50 ± 1.00
62.75 ± 8.34 56.75 ± 0.85 7.50 ± 1.73
62.75 ± 7.04 57.50 ± 5.45 9.25 ± 1.89
42.25 ± 3.40 42.25 ± 2.99 5.75 ± 1.26
41.50 ± 7.59 42.00 ± 6.68 5.00 ± 2.16
37.25 ± 22.51 37.00 ± 14.72 4.25 ± 3.86
60.50 ± 12.82 52.00 ± 10.39 4.67 ± 0.47
54.25 ± 6.54 48.50 ± 12.84 5.00 ± 2.74
54.50 ± 7.09 445.75 ± 4.44 5.00 ± 0.82
48.50 ± 10.88 45.17 ± 9.70 5.33 ± 2.42
63.71 ± 17.74 56.71 ± 16.54 6.17 ± 3.29
68.00 ± 24.99 63.40 ± 2.48 8.20 ± 3.49
TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low
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role in fetal programming [29].
Several animal studies have suggested that fetal nutri-
tion acts as epigenetic stimuli to bring about changes in
the regulation of gene expression [3]. In our research
and some of other research, the epigenetic adaptation
persisted from 2 weeks to 4 months of age, which lead
to a prediabetic state in the rats [3]. In our research, sev-
eral gene expressions such as ACE, ATIA, eNOS and Tn
I were significantly increased in the FR group.
Glucocorticoid steroids may play a key role in the fetal
origins of hypertension, because the increased BP in off-
spring of LPD dams depends not only on an intact adrenal
gland in postnatal life [23], but also on maternal gluco-
corticoid synthesis during pregnancy [30]. Glucocorticoid
steroids may up-regulate the actions of the RAS at the
level of angiotensinogen synthesis, ACE, and more im-
portantly, the AT 1 receptor [23, 31].
The effects of antihypertensive drugs on fetal pro-
gramming model are different according to investigators.
Sherman, et al. administrated the ACE inhibitor capto-
pril, for a period of 18 days, beginning at 23 weeks after
birth. This gets rid of the hypertension of LPD offspring
for some 7–8 weeks after the cessation of treatment
[32]. Sherman, et al. have also previously demonstrated
that the specific AT1 antagonist losartan at 2–4 weeks of
age prevents an increase in BP in offspring of LPD fed
dams during pregnancy [32]. We induced the fetal pro-
graming model using food restriction during pregnancy
and lactation period. We planned losartan treatment at
the pilot study from postanatal 4 week to 20 week.
There was no response to reduce blood pressure and
gene change after losartan treatment postnatally. There-
fore, we decided on a postnatally amlodipine-losartan
combination in fetal programming models. The amlodi-
pine- losartan combination treatment reduced obesity,
hypertension, hypertriglyceridemia and gene changes
such as ACE, AT IA, eNOS and Tn I in our study.
In our previous study, we studied changes of gene ex-
pressions in a spontaneously hypertensive rat model
after losartan treatment. Systolic blood pressure was sig-
nificantly decreased in the losartan group compared with
the hypertension group in weeks 3 and 5. ACE and
ATIA proteins in the losartan group were lower than
hypertension group in week 5 [33].
Losartan treatment has been reported to significantly
reduce body weight in low-protein-exposed rats, but not
in animals fed a control maternal diet (18 % casein).
At 12 weeks of age, low-protein-exposed rats treated
with losartan at a young age remained normotensive and
had body weights similar to those of untreated rats ex-
posed to 9 % casein diets [31]. In our research, amlodipine-
losartan combination treatment from week 4 until week 20
decreased BP, body weight and abdominal fat tissues.Ceravolo, et al. wrote that at 14 weeks of age, losartan
(10 mg/kg, for 15 days) or enalapril treatments stabilized
the BP levels and reduced the response to Ang II [19].
Sherman and Langley- Evans [32] found that hyperten-
sion does not develop at eight weeks after captopril
treatment in a LPD exposed fetal model at postnatal
weeks 2–4. This length of treatment could have been
sufficient to inhibit the intrarenal angiotensin system,
but it was too late in rat renal development to be able to
affect nephrogenesis.
Local RAS in the heart, brain and kidney may play a
critical role in determining BP.
There are some controversies about the result of ACE
activities. Ceravolo, et al. reported no alterations on
plasma or tissue ACE activity in intrauterine undernour-
ished rats [19]. However, Langley-Evans SC, et al. have
found increased plasma ACE activity in rats exposed to
a LPD in utero [34]. These discrepancies observed might
be due to differences in the feeding protocol used.
In our study, ACE protein expressions were significantly
increased in the FR group and reduced after amlodipine-
losartan combination treatment.
Amlodipine-losartan combination have become an ex-
citing therapy for patients with hypertension who have
cardiovascular co-morbidities [35]. The advantages of
combining amlodipine and losartan include a possible
lower incidence rate of side effects such as edema, and
increased compliance because of its ease of dosing and
its improved tolerability, which may also contribute to
greater BP-lowering effects [35] .
The main purpose of fixed-dose combination antihy-
pertensive medications is to significantly improve drug
intake, thus improving patient adherence, and, ultim-
ately, to maximize the clinical efficacy and minimize the
adverse effects found in monotherapy.
Experimental research suggest that it is the timing of
the prenatal insult that is critical to the development of
hypertension [6]. Animal studies show that when the pre-
natal insult occurs during the nephrogenic period, signifi-
cant increases in mean arterial pressure are noted [6, 36].
Both clinical and experimental evidence suggest that
sex may have an important impact on the development
of cardiovascular disease that may reflect the regulation
of the RAS by gonadal hormones including testosterone
and estrogen [2]. Therefore, we performed research in
only male offspring to exclude the hormone effect on
fetal programming.
Studies into the mechanisms involved in the alterations
of endothelium-dependent responses is critical for under-
standing the pathways by which intrauterine under-
nutrition leads to endothelium dysfunction and therefore
to the development of hypertension and other cardiovascu-
lar diseases. Franco, et al. reported that reduced activity of
NOS has been described in intrauterine undernourished
Lee et al. Clinical Hypertension  (2016) 22:12 Page 9 of 10rats [37]. This result is different from our data. In our
study, protein expressions of eNOS were significantly in-
creased in the FR group and significantly decreased after
amlodipine-losartan combination treatment.
Conclusions
In conclusion, we established fetal programming model.
Fetal under-nutrition only during late pregnancy resulted
in obesity, high blood pressure, hypertriglyceridemia and
several gene changes in offspring. Amlodipine-losartan
combination treatment reduced obesity, hypertension,
hypertriglyceridemia and the changes in genes.
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